Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 11 | 2016 | 342 | 2.030 |
Why?
|
| Alzheimer Disease | 17 | 2013 | 565 | 1.470 |
Why?
|
| Neuropsychological Tests | 11 | 2016 | 517 | 1.020 |
Why?
|
| Dementia | 9 | 2013 | 158 | 0.790 |
Why?
|
| Geriatric Assessment | 3 | 2011 | 107 | 0.710 |
Why?
|
| Depression | 5 | 2015 | 943 | 0.640 |
Why?
|
| Cognition | 6 | 2019 | 513 | 0.630 |
Why?
|
| Malingering | 2 | 2015 | 36 | 0.580 |
Why?
|
| Apolipoproteins E | 4 | 2012 | 92 | 0.520 |
Why?
|
| Memory Disorders | 1 | 2015 | 111 | 0.460 |
Why?
|
| Apolipoprotein E4 | 1 | 2012 | 31 | 0.420 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2012 | 142 | 0.350 |
Why?
|
| Apathy | 3 | 2013 | 28 | 0.330 |
Why?
|
| Aged | 27 | 2015 | 14862 | 0.330 |
Why?
|
| Methylphenidate | 3 | 2013 | 97 | 0.310 |
Why?
|
| Psychomotor Agitation | 2 | 2006 | 63 | 0.300 |
Why?
|
| Aged, 80 and over | 15 | 2015 | 4848 | 0.280 |
Why?
|
| Angioplasty | 2 | 2019 | 118 | 0.280 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 1753 | 0.280 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2019 | 134 | 0.270 |
Why?
|
| Cohort Studies | 4 | 2009 | 2358 | 0.260 |
Why?
|
| Mental Disorders | 2 | 2006 | 659 | 0.260 |
Why?
|
| Patient Selection | 1 | 2009 | 592 | 0.250 |
Why?
|
| Middle Aged | 19 | 2015 | 21147 | 0.240 |
Why?
|
| Circadian Rhythm | 1 | 2006 | 218 | 0.240 |
Why?
|
| Male | 32 | 2015 | 37321 | 0.240 |
Why?
|
| Memory | 3 | 2015 | 214 | 0.230 |
Why?
|
| Female | 30 | 2015 | 38074 | 0.230 |
Why?
|
| Humans | 41 | 2019 | 68618 | 0.230 |
Why?
|
| tau Proteins | 1 | 2003 | 61 | 0.220 |
Why?
|
| Stents | 2 | 2019 | 657 | 0.220 |
Why?
|
| Stroke | 4 | 2019 | 2163 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 1 | 2003 | 191 | 0.200 |
Why?
|
| Hospitalization | 3 | 2014 | 978 | 0.180 |
Why?
|
| Risk Factors | 9 | 2019 | 5731 | 0.170 |
Why?
|
| Firearms | 1 | 1999 | 26 | 0.170 |
Why?
|
| Biomarkers | 2 | 2007 | 1593 | 0.170 |
Why?
|
| Education, Medical, Undergraduate | 2 | 2011 | 148 | 0.150 |
Why?
|
| Nerve Degeneration | 2 | 2011 | 134 | 0.150 |
Why?
|
| Down Syndrome | 2 | 2011 | 120 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 82 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 176 | 0.130 |
Why?
|
| Attention | 2 | 2013 | 225 | 0.130 |
Why?
|
| Cerebrovascular Disorders | 2 | 1998 | 182 | 0.130 |
Why?
|
| Age Factors | 5 | 2019 | 1864 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2013 | 782 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 2 | 2013 | 221 | 0.120 |
Why?
|
| Cerebral Revascularization | 1 | 2014 | 45 | 0.120 |
Why?
|
| Sleep Wake Disorders | 2 | 1992 | 94 | 0.120 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2014 | 4 | 0.120 |
Why?
|
| Age of Onset | 2 | 2012 | 188 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 31 | 0.110 |
Why?
|
| Demyelinating Diseases | 1 | 2014 | 57 | 0.110 |
Why?
|
| South Carolina | 6 | 2014 | 2752 | 0.110 |
Why?
|
| Racism | 1 | 2014 | 59 | 0.110 |
Why?
|
| Program Development | 2 | 2011 | 240 | 0.110 |
Why?
|
| Genotype | 3 | 2012 | 786 | 0.110 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2015 | 111 | 0.110 |
Why?
|
| Exercise | 1 | 2019 | 658 | 0.110 |
Why?
|
| Sleep | 1 | 2015 | 263 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2012 | 207 | 0.100 |
Why?
|
| Psychometrics | 2 | 2013 | 514 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2014 | 335 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2012 | 122 | 0.090 |
Why?
|
| Neurologic Examination | 1 | 2011 | 107 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 498 | 0.090 |
Why?
|
| Mentors | 1 | 2011 | 81 | 0.090 |
Why?
|
| Adult | 8 | 2015 | 21403 | 0.090 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 378 | 0.090 |
Why?
|
| Hospitals, Veterans | 1 | 2011 | 147 | 0.090 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2010 | 4 | 0.090 |
Why?
|
| Statistics as Topic | 1 | 2011 | 219 | 0.090 |
Why?
|
| Norepinephrine | 1 | 2011 | 276 | 0.090 |
Why?
|
| Stroke Rehabilitation | 1 | 2014 | 335 | 0.090 |
Why?
|
| Focus Groups | 1 | 2011 | 247 | 0.090 |
Why?
|
| Schools, Medical | 1 | 2011 | 157 | 0.090 |
Why?
|
| Behavior Therapy | 4 | 1997 | 297 | 0.080 |
Why?
|
| Models, Psychological | 1 | 2010 | 180 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 786 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 931 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2014 | 665 | 0.080 |
Why?
|
| Students, Medical | 1 | 2011 | 210 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2004 | 234 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 1465 | 0.080 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 1054 | 0.080 |
Why?
|
| Research Design | 1 | 2013 | 729 | 0.080 |
Why?
|
| Mental Status Schedule | 3 | 1999 | 31 | 0.080 |
Why?
|
| Observer Variation | 1 | 2009 | 330 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1046 | 0.080 |
Why?
|
| Geriatrics | 1 | 2007 | 69 | 0.070 |
Why?
|
| United States | 5 | 2019 | 7367 | 0.070 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 546 | 0.070 |
Why?
|
| General Surgery | 1 | 2007 | 95 | 0.070 |
Why?
|
| Aging | 2 | 2007 | 911 | 0.070 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 955 | 0.070 |
Why?
|
| Lipids | 1 | 2007 | 298 | 0.070 |
Why?
|
| Registries | 1 | 2009 | 733 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2011 | 2550 | 0.060 |
Why?
|
| Hypertension | 1 | 2014 | 1535 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2013 | 1738 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2012 | 7277 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 2077 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2004 | 64 | 0.060 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.060 |
Why?
|
| Minocycline | 1 | 2004 | 61 | 0.060 |
Why?
|
| Pick Disease of the Brain | 1 | 2003 | 4 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 2223 | 0.060 |
Why?
|
| Surveys and Questionnaires | 2 | 2009 | 2800 | 0.060 |
Why?
|
| Curriculum | 1 | 2007 | 575 | 0.060 |
Why?
|
| Rural Population | 1 | 2007 | 398 | 0.060 |
Why?
|
| Activities of Daily Living | 3 | 2014 | 319 | 0.060 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2003 | 137 | 0.060 |
Why?
|
| Veterans | 1 | 2011 | 904 | 0.050 |
Why?
|
| Craniocerebral Trauma | 1 | 2003 | 50 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 179 | 0.050 |
Why?
|
| Educational Status | 1 | 2003 | 273 | 0.050 |
Why?
|
| Patient Discharge | 2 | 2014 | 294 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2007 | 596 | 0.050 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 3259 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 1619 | 0.050 |
Why?
|
| Incidence | 3 | 2014 | 1603 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2019 | 7029 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1140 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 940 | 0.040 |
Why?
|
| Animals | 3 | 2012 | 20881 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2003 | 621 | 0.040 |
Why?
|
| Combined Modality Therapy | 3 | 1997 | 951 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2019 | 236 | 0.040 |
Why?
|
| Day Care, Medical | 1 | 1997 | 18 | 0.040 |
Why?
|
| Maze Learning | 2 | 2011 | 138 | 0.040 |
Why?
|
| Aphasia | 2 | 1991 | 119 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 1997 | 22 | 0.040 |
Why?
|
| Awareness | 1 | 1997 | 81 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2003 | 2279 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 1999 | 1040 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 805 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 8912 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 948 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 1997 | 170 | 0.030 |
Why?
|
| Brain | 3 | 2014 | 2176 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2007 | 3705 | 0.030 |
Why?
|
| Association Learning | 1 | 2015 | 36 | 0.030 |
Why?
|
| Smoking | 1 | 2003 | 1452 | 0.030 |
Why?
|
| Dangerous Behavior | 1 | 1994 | 8 | 0.030 |
Why?
|
| Social Participation | 1 | 2014 | 16 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 85 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2015 | 249 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 260 | 0.030 |
Why?
|
| Length of Stay | 1 | 1997 | 780 | 0.030 |
Why?
|
| Osmosis | 1 | 2014 | 38 | 0.030 |
Why?
|
| Sex Factors | 2 | 2002 | 1266 | 0.030 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2014 | 37 | 0.030 |
Why?
|
| Malnutrition | 1 | 2014 | 28 | 0.030 |
Why?
|
| Automobile Driving | 1 | 2014 | 88 | 0.030 |
Why?
|
| Massachusetts | 1 | 1993 | 28 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 1994 | 216 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 506 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2013 | 107 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2014 | 157 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2013 | 62 | 0.030 |
Why?
|
| Psychophysiologic Disorders | 1 | 1992 | 20 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2019 | 2007 | 0.030 |
Why?
|
| Restless Legs Syndrome | 1 | 1992 | 18 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2015 | 418 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2014 | 384 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1992 | 40 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 567 | 0.030 |
Why?
|
| Anti-Anxiety Agents | 1 | 1992 | 107 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 1992 | 130 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 1993 | 344 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1992 | 91 | 0.020 |
Why?
|
| Caregivers | 1 | 1994 | 365 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 1991 | 70 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 134 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 286 | 0.020 |
Why?
|
| Physical Exertion | 1 | 1991 | 75 | 0.020 |
Why?
|
| Locus Coeruleus | 1 | 2011 | 55 | 0.020 |
Why?
|
| Personality Inventory | 1 | 1991 | 197 | 0.020 |
Why?
|
| Receptors, Lipoprotein | 1 | 2010 | 11 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1991 | 210 | 0.020 |
Why?
|
| Spain | 1 | 2010 | 34 | 0.020 |
Why?
|
| Functional Laterality | 1 | 1991 | 240 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 442 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1745 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2010 | 161 | 0.020 |
Why?
|
| Feeding and Eating Disorders | 1 | 1991 | 106 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Bromocriptine | 1 | 1988 | 8 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2003 | 1553 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1033 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 2334 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2007 | 94 | 0.020 |
Why?
|
| Albumins | 1 | 2007 | 72 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2007 | 113 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 184 | 0.020 |
Why?
|
| Mice | 2 | 2011 | 8474 | 0.020 |
Why?
|
| Educational Measurement | 1 | 2007 | 254 | 0.020 |
Why?
|
| Social Environment | 1 | 2007 | 182 | 0.020 |
Why?
|
| Calbindin 2 | 1 | 2004 | 6 | 0.020 |
Why?
|
| Escape Reaction | 1 | 2004 | 10 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2004 | 30 | 0.020 |
Why?
|
| Calbindins | 1 | 2004 | 23 | 0.020 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2004 | 21 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 27 | 0.020 |
Why?
|
| Leukocyte Common Antigens | 1 | 2004 | 41 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2007 | 622 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2004 | 166 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 248 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 5717 | 0.010 |
Why?
|
| Microglia | 1 | 2004 | 143 | 0.010 |
Why?
|
| Disease Progression | 1 | 2007 | 1038 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1174 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2004 | 470 | 0.010 |
Why?
|
| Likelihood Functions | 1 | 2002 | 106 | 0.010 |
Why?
|
| Age Distribution | 1 | 2002 | 320 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1030 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 386 | 0.010 |
Why?
|
| Family | 1 | 2003 | 293 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 563 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2002 | 880 | 0.010 |
Why?
|
| Psychotherapy, Brief | 1 | 1997 | 30 | 0.010 |
Why?
|
| Demography | 1 | 1998 | 279 | 0.010 |
Why?
|
| Southeastern United States | 1 | 1998 | 281 | 0.010 |
Why?
|
| Agnosia | 1 | 1997 | 9 | 0.010 |
Why?
|
| Sick Role | 1 | 1997 | 40 | 0.010 |
Why?
|
| Aggression | 1 | 1997 | 98 | 0.010 |
Why?
|
| Patient Care Team | 1 | 1997 | 311 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1994 | 32 | 0.010 |
Why?
|
| Behavior | 1 | 1993 | 59 | 0.010 |
Why?
|
| Acute Disease | 1 | 1994 | 658 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1994 | 649 | 0.010 |
Why?
|
| Program Evaluation | 1 | 1994 | 502 | 0.010 |
Why?
|